| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 676,00 | 677,40 | 15.02. | |
| 674,00 | 678,60 | 13.02. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Regeneron to present Phase 3 data on novel allergy antibodies at AAAAI | ||
| Di | Regeneron Pharmaceuticals, Inc.: Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy | 36 abstracts to be presented across Regeneron-invented therapies, including first-time Phase 3 presentations for two distinct investigational allergen-blocking antibodies for cat and birch allergies... ► Artikel lesen | |
| 04.02. | REGENERON PHARMACEUTICALS, INC. - 10-K, Annual Report | ||
| 02.02. | These Analysts Revise Their Forecasts On Regeneron Pharmaceuticals After Q4 Results | ||
| 02.02. | BMO Capital bestätigt "Outperform"-Rating für Regeneron-Aktie mit Kursziel 850 $ |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| REGENERON PHARMACEUTICALS INC | 675,60 | -0,12 % |
